NVAX logo

Novavax (NVAX) Company Overview

Profile

Full Name:

Novavax, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 5, 1995

Indexes:

Not included

Description:

Novavax, Inc. is a biotechnology company focused on developing vaccines to prevent infectious diseases. It specializes in protein-based vaccines and has gained attention for its COVID-19 vaccine. The company aims to improve global health through innovative vaccine solutions and partnerships with governments and organizations.

Events Calendar

Earnings

Next earnings date:

May 9, 2025

Recent quarterly earnings:

Feb 27, 2025

Recent annual earnings:

Feb 27, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 10, 2019

Analyst ratings

Recent major analysts updates

Dec 10, 24 HC Wainwright & Co.
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Nov 12, 24 HC Wainwright & Co.
Buy
Aug 12, 24 JP Morgan
Underweight
Aug 12, 24 B. Riley Securities
Buy
Aug 2, 24 B. Riley Securities
Buy
Jul 30, 24 JP Morgan
Underweight
Jun 14, 24 B of A Securities
Neutral
May 23, 24 B. Riley Securities
Buy
May 13, 24 TD Cowen
Hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Novavax?
  • Does Novavax pay dividends?
  • What sector is Novavax in?
  • What industry is Novavax in?
  • What country is Novavax based in?
  • When did Novavax go public?
  • Is Novavax in the S&P 500?
  • Is Novavax in the NASDAQ 100?
  • Is Novavax in the Dow Jones?
  • When was Novavax's last earnings report?
  • When does Novavax report earnings?
  • Should I buy Novavax stock now?

What is the ticker symbol for Novavax?

The ticker symbol for Novavax is NASDAQ:NVAX

Does Novavax pay dividends?

No, Novavax does not pay dividends

What sector is Novavax in?

Novavax is in the Healthcare sector

What industry is Novavax in?

Novavax is in the Biotechnology industry

What country is Novavax based in?

Novavax is headquartered in United States

When did Novavax go public?

Novavax's initial public offering (IPO) was on December 5, 1995

Is Novavax in the S&P 500?

No, Novavax is not included in the S&P 500 index

Is Novavax in the NASDAQ 100?

No, Novavax is not included in the NASDAQ 100 index

Is Novavax in the Dow Jones?

No, Novavax is not included in the Dow Jones index

When was Novavax's last earnings report?

Novavax's most recent earnings report was on Feb 27, 2025

When does Novavax report earnings?

The next expected earnings date for Novavax is May 9, 2025

Should I buy Novavax stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions